HOME Top Market Reports Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020

Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: November 2015
Report Code: BT 2680

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The oligonucleotide synthesis market is expected to reach USD 1,918.6 Million at a CAGR of 10.1% by 2020 from USD 1,078.1 Million in 2015. Major factors driving the growth of this market include increasing R&D expenses in pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes. The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, genetic engineering, and synthetic biology also play a vital role in the development of this market. In addition, emerging Asian markets and the growing field of NGS have opened an array of opportunities for players in the oligonucleotide synthesis market. However, price erosion and lack of regulations for therapeutic oligonucleotides could hinder the growth of this market.

Geographically, North America is expected to dominate the market in 2015, followed by Europe. However, the Asia-Pacific oligonucleotide synthesis market is slated to grow at the highest CAGR owing to the growing availability of synthesized oligos, increase in R&D funding and activities, and increasing focus of prominent players in in the APAC region.

Key market players include Agilent Technologies, Inc. (U.S.), BioAutomation Corporation (U.S.), BioSearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign Inc. (Japan), GE Healthcare (U.K.), Gen9 Inc. (U.S.), GenScript Inc. (U.S.), Integrated DNA Technologies (IDT) (U.S.), Nitto Denko Avecia Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), TriLink Biotechnologies (U.S.), and Sigma-Aldrich Corporation (U.S.).

Stakeholders include life science instrumentation and reagent companies, pharmaceutical and biotechnology companies, hospitals/clinics, academic researchers/government research organizations, private research institutes, custom oligonucleotide service providers, contract manufacturing organizations (CMOs), oligonucleotide equipment manufacturers, contract research organizations (CROs), market research and consulting firms, and venture capitalists.

Scope of the Report

This report covers the global oligonucleotide synthesis market by products and services, applications, end users, and regions.

Oligonucleotide Synthesis Market, by Products and Services

  • Synthesized Oligonucleotides
    • By Product
      • Primers
      • Probes
      • Large-scale Synthesis Oligos
      • Intermediate-scale Synthesis Oligos
    • By Service
      • Custom Oligos
      • Predesigned Oligos
  • Reagents
  • Equipment

Oligonucleotide Synthesis Market, by Application

  • Research
    • PCR
    • QPCR
    • DNA Sequencing
    • Gene Synthesis
    • Other Research Applications [Nucleic Acid-based Testing, Isothermal Nucleic Acid Technology, Binding Studies, Gel Shift Assays, and Fluorescence In Situ Hybridization (FISH)]
  • Diagnostic
  • Therapeutic
    • DNA/Antisense Oligos
    • RNA
    • Nucleic Acid Aptamers
    • Other Therapeutic Applications (Immunostimulatory Agents in Immunotherapy Applications)

Oligonucleotide Synthesis Market, by End User

  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Other End Users

Oligonucleotide Synthesis Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of the Europe (RoE)
  • Asia-Pacific
  • Latin America (LATAM)
  • Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.

The following customization options are available for the report:

  • Company Information

Detailed analysis and profiling of additional market players (up to 5)

  • Further split of the Asia-Pacific Oligonucleotide Synthesis Market

Oligonucleotide synthesis market size and growth rate estimates for Japan, China, India, and the Rest of Asia-Pacific (RoAPAC)

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Industry Insights
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 33)

4 Premium Insights (Page No. - 38)
    4.1 Oligonucleotide Synthesis Market Overview
    4.2 Market, By Products & Services
    4.3 Market, By Application
    4.4 Market, By End User
    4.5 Geographic Snapshot of the Market

5 Market Overview (Page No. - 42)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Products & Services
           5.2.2 By Application
           5.2.3 By End User
           5.2.4 By Region
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Increasing R&D Expenditure in Pharmaceutical & Biotechnology Companies
                    5.3.1.2 Growing Field of Molecular Diagnostics
                    5.3.1.3 Increasing Government Investments to Develop Genomic Technologies
                    5.3.1.4 Rise in Venture Capital Investments
                    5.3.1.5 Increasing Demand for Synthetic Genes
           5.3.2 Restraints
                    5.3.2.1 Price Erosion of Synthesized Oligos
                    5.3.2.2 Lack of Regulations for Therapeutic Oligos
           5.3.3 Opportunities
                    5.3.3.1 Emerging Asian Markets
                    5.3.3.2 Developing Field of Next-Generation Sequencing
           5.3.4 Challenges
                    5.3.4.1 Localization of Business
                    5.3.4.2 Large-Scale Synthesis of Oligonucleotides

6 Industry Insights (Page No. - 52)
    6.1 Introduction
           6.1.1 Industry Trends
    6.2 Porter’s Five Forces Analysis
           6.2.1 Threat From New Entrants
           6.2.2 Threat From Substitutes
           6.2.3 Bargaining Power of Suppliers
           6.2.4 Bargaining Power of Buyers
           6.2.5 Intensity of Competitive Rivalry
    6.3 Supply Chain Analysis
           6.3.1 Key Influencers

7 Oligonucleotide Synthesis Market, By Products & Services (Page No. - 57)
    7.1 Introduction
    7.2 Synthesized Oligonucleotides
           7.2.1 Synthesized Oligonucleotides Market, By Product
                    7.2.1.1 Primers
                    7.2.1.2 Probes
                    7.2.1.3 Large-Scale Synthesis Oligos
                    7.2.1.4 Intermediate-Scale Synthesis Oligonucleotides
           7.2.2 Synthesized Oligonucleotides Market, By Service
                    7.2.2.1 Custom Oligonucleotides
                    7.2.2.2 Pre-Designed Oligonucleotides
           7.2.3 Reagents
           7.2.4 Equipment

8 Oligonucleotide Synthesis Market, By Application (Page No. - 78)
    8.1 Introduction
    8.2 Research
           8.2.1 PCR
           8.2.2 Qpcr
           8.2.3 Sequencing
           8.2.4 Gene Synthesis
           8.2.5 Other Research Applications
    8.3 Diagnostics
    8.4 Therapeutics
           8.4.1 DNA/Antisense Oligos
           8.4.2 Rnai
           8.4.3 Nucleic Acid Aptamers
           8.4.4 Other Therapeutic Applications

9 Oligonucleotide Synthesis Market, By End User (Page No. - 105)
    9.1 Introduction
    9.2 Academic Research Institutes
    9.3 Diagnostic Laboratories
    9.4 Pharmaceutical and Biotechnology Companies
    9.5 Other End Users

10 Regional Analysis (Page No. - 116)
     10.1 Introduction
     10.2 Pest Analysis
             10.2.1 Political Factors
             10.2.2 Economic Factors
             10.2.3 Social Factors
             10.2.4 Technological Factors
     10.3 North America
             10.3.1 U.S.
             10.3.2 Canada
     10.4 Europe
             10.4.1 Germany
             10.4.2 France
             10.4.3 U.K.
             10.4.4 Rest of Europe (RoE)
     10.5 Asia-Pacific (APAC)
     10.6 Latin America (Latam)
     10.7 Middle East and Africa (MEA)

11 Competitive Landscape (Page No. - 164)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 New Product Launches
             11.3.2 Partnerships, Agreements, Contracts, and Collaborations
             11.3.3 Expansions
             11.3.4 Acquisitions

12 Company Profile (Page No. - 172)
     12.1 Introduction
     12.2 Integrated DNA Technologies, Inc. (IDT)
     12.3 Sigma-Aldrich Corporation
     12.4 Eurofins Genomics
     12.5 Thermo Fisher Scientific, Inc.
     12.6 Bioautomation Corporation
     12.7 Agilent Technologies, Inc.
     12.8 Biosearch Technologies, Inc.
     12.9 Eurogentec S.A.
     12.10 General Electric Company (GE)
     12.11 Gen9, Inc.
     12.12 Genedesign, Inc.
     12.13 Genscript Usa Inc.
     12.14 Nitto Denko Avecia Inc. (Avecia)
     12.15 Trilink Biotechnologies, Inc.

*Details on Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 215)
     13.1 Insights From Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments, By Company, 2012-2015
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports


List of Tables (183 Tables)

Table 1 Increasing R&D Expenditure in Pharmaceutical and Biotechnology Companies is Propelling the Growth of Oligonucleotide Synthesis Market
Table 2 Price Erosion of Synthesized Oligos Restraints the Growth of the Market
Table 3 Emerging Asia-Pacific Markets are Paving New Growth Avenues for Players in Oligonucleotide Synthesis Market
Table 4 Localization of Business Can Be A Major Challenge for the Growth of the Market
Table 5 Global Synthesized Oligonucleotides Market, By Region, 2013-2020 (USD Million)
Table 6 North America: Synthesized Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 7 Europe: Synthesized Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 8 Global Synthesized Oligonucleotides Market, By Type, 2013-2020 (USD Million)
Table 9 Global Primers Market, By Region, 2013-2020 (USD Million)
Table 10 North America: Primers Market, By Country, 2013-2020 (USD Million)
Table 11 Europe: Primers Market, By Country, 2013-2020 (USD Million)
Table 12 Global Probes Market, By Region, 2013-2020 (USD Million)
Table 13 North America: Probes Market, By Country, 2013-2020 (USD Million)
Table 14 Europe: Probes Market, By Country, 2013-2020 (USD Million)
Table 15 Global Large-Scale Synthesis Oligonucleotides Market, By Region, 2013-2020 (USD Million)
Table 16 North America: Large-Scale Synthesis Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 17 Europe: Large-Scale Synthesis Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 18 Global Intermediate-Scale Synthesis Oligonucleotides Market, By Region, 2013-2020 (USD Million)
Table 19 North America: Intermediate Scale Synthesis Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 20 Europe: Intermediate Scale Synthesis Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 21 Global Synthesized Oligonucleotides Market, By Service, 2013-2020 (USD Million)
Table 22 Global Custom Oligonucleotides Market, By Region, 2013-2020 (USD Million)
Table 23 North America: Custom Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 24 Europe: Custom Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 25 Global Pre-Designed Oligonucleotides Market, By Region, 2013-2020 (USD Million)
Table 26 North America: Pre-Designed Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 27 Europe: Pre-Designed Oligonucleotides Market, By Country, 2013-2020 (USD Million)
Table 28 Global Oligonucleotide Synthesis Reagents Market, By Region, 2013-2020 (USD Million)
Table 29 North America: Oligonucleotide Synthesis Reagents Market, By Country, 2013-2020 (USD Million)
Table 30 Europe: Oligonucleotide Synthesis Reagents Market, By Country, 2013-2020 (USD Million)
Table 31 Global Oligonucleotide Synthesis Equipment Market, By Region, 2013-2020 (USD Million)
Table 32 North America: Oligonucleotide Synthesis Equipment Market, By Country, 2013-2020 (USD Million)
Table 33 Europe: Oligonucleotide Synthesis Equipment Market, By Country, 2013-2020 (USD Million)
Table 34 Global Oligonucleotide Synthesis Market Size, By Application, 2013–2020 (USD Million)
Table 35 Global Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 36 Global Market Size for Research Applications, By Region, 2013–2020 (USD Million)
Table 37 North America: Market Size for Research Applications, By Country, 2013–2020 (USD Million)
Table 38 Europe: Market Size for Research Applications, By Country, 2013–2020 (USD Million)
Table 39 Global Market Size for PCR Applications, By Region, 2013–2020 (USD Million)
Table 40 North America: Market Size for PCR Applications, By Country, 2013–2020 (USD Million)
Table 41 Europe: Market Size for PCR Applications, By Country, 2013–2020 (USD Million)
Table 42 Global Market Size for Qpcr Applications, By Region, 2013–2020 (USD Million)
Table 43 North America: Market Size for Qpcr Applications, By Country, 2013–2020 (USD Million)
Table 44 Europe: Market for Qpcr Applications, By Country, 2013–2020 (USD Million)
Table 45 Global Oligonucleotide Synthesis Market Size for Sequencing Applications, By Region, 2013–2020 (USD Million)
Table 46 North America: Market Size for Sequencing Applications, By Country, 2013–2020 (USD Million)
Table 47 Europe: Market Size for Sequencing Applications, By Country, 2013–2020 (USD Million)
Table 48 Global Oligonucleotide Synthesis Market Size for Gene Synthesis Applications, By Region, 2013–2020 (USD Million)
Table 49 North America: Market Size for Gene Synthesis Applications, By Country, 2013–2020 (USD Million)
Table 50 Europe: Market Size for Gene Synthesis Applications, By Country, 2013–2020 (USD Million)
Table 51 Global Oligonucleotide Synthesis Market Size for Other Research Applications, By Region, 2013–2020 (USD Million)
Table 52 North America: Market Size for Other Research Applications, By Country, 2013–2020 (USD Million)
Table 53 Europe: Market Size for Other Research Applications, By Country, 2013–2020 (USD Million)
Table 54 Global Oligonucleotide Synthesis Market Size for Diagnostic Applications, By Region, 2013–2020 (USD Million)
Table 55 North America: Market Size for Diagnostic Applications, By Country, 2013–2020 (USD Million)
Table 56 Europe: Market Size for Diagnostic Applications, By Country, 2013–2020 (USD Million)
Table 57 Global Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 58 Global Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Region, 2013–2020 (USD Million)
Table 59 North America: Market Size for Therapeutic Applications, By Country, 2013–2020 (USD Million)
Table 60 Europe: Market Size for Therapeutic Applications, By Country, 2013–2020 (USD Million)
Table 61 Global Oligonucleotide Synthesis Market Size for DNA/Antisense Oligos Applications, By Region, 2013–2020 (USD Million)
Table 62 North America: Market Size for DNA/Antisense Oligos Applications, By Country, 2013–2020 (USD Million)
Table 63 Europe: Market Size for DNA/Antisense Oligos Applications, By Country, 2013–2020 (USD Million)
Table 64 Global Oligonucleotide Synthesis Market Size for Rnai Applications, By Region, 2013–2020 (USD Million
Table 65 North America: Market Size for Rnai Applications, By Country, 2013–2020 (USD Million)
Table 66 Europe: Market Size for Rnai Applications, By Country, 2013–2020 (USD Million)
Table 67 Global Market Size for Nucleic Acid Aptamer Applications, By Region, 2013–2020 (USD Million)
Table 68 North America: Market Size for Nucleic Acid Aptamer Applications, By Country, 2013–2020 (USD Million)
Table 69 Europe: Market Size for Nucleic Acid Aptamer Applications, By Country, 2013–2020 (USD Million)
Table 70 Global Oligonucleotide Synthesis Market Size for Other Therapeutic Applications, By Region, 2013–2020 (USD Thousand)
Table 71 North America: Market Size for Other Therapeutic Applications, By Country, 2013–2020 (USD Thousand)
Table 72 Europe: Market Size for Other Therapeutic Applications, By Country, 2013–2020 (USD Thousand)
Table 73 Global Oligonucleotide Synthesis Market, By End User, 2013–2020 (USD Million)
Table 74 Global Oligonucleotide Synthesis Market Size for Academic Research Institutes, By Region, 2013-2020 (USD Million)
Table 75 North America: Market Size for Academic Research Institutes, By Country, 2013-2020 (USD Million)
Table 76 Europe: Market Size for Academic Research Institutes, By Country, 2013-2020 (USD Million)
Table 77 Global Oligonucleotide Synthesis Market Size for Diagnostic Laboratories, By Region, 2013-2020 (USD Million)
Table 78 North America: Market Size for Diagnostic Laboratories, By Country, 2013-2020 (USD Million)
Table 79 Europe: Market Size for Diagnostic Laboratories, By Country, 2013-2020 (USD Million)
Table 80 Global Oligonucleotide Synthesis Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2013-2020 (USD Million)
Table 81 North America: Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2013-2020 (USD Million)
Table 82 Europe: Oligonucleotide Synthesis Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2013-2020 (USD Million)
Table 83 Global Oligonucleotide Synthesis Market Size for Other End Users, By Region, 2013-2020 (USD Million)
Table 84 North America: Market Size for Other End Users, By Country, 2013-2020 (USD Million)
Table 85 Europe: Market Size for Other End Users, By Country, 2013-2020 (USD Million)
Table 86 Global Oligonucleotide Synthesis Market Size, By Region, 2013–2020 (USD Million)
Table 87 North America: Market Size, By Country, 2013–2020 (USD Million)
Table 88 Europe: Market Size, By Country, 2013–2020 (USD Million)
Table 89 North America: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 90 North America: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 91 North America: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 92 North America: Market Size, By Application, 2013–2020 (USD Million)
Table 93 North America: Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 94 North America: Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 95 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 96 U.S.: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 97 U.S.: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 98 U.S.: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 99 U.S.: Market Size, By Application, 2013–2020 (USD Million)
Table 100 U.S.: Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 101 U.S.: Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 102 U.S.: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 103 Canada: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 104 Canada: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 105 Canada: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 106 Canada: Market Size, By Application, 2013–2020 (USD Million)
Table 107 Canada: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 108 Canada: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 109 Canada: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 110 Europe: Market Size, By Products & Services, 2013–2020 (USD Million)
Table 111 Europe: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 112 Europe: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 113 Europe: Oligonucleotide Synthesis Market Size, By Application, 2013–2020 (USD Million)
Table 114 Europe: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 115 Europe: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 116 Europe: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 117 Germany: Oligonucleotide Synthesis Market Size, By Products & Services, 2013–2020 (USD Million)
Table 118 Germany: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 119 Germany: Synthesized Oligonucleotides Market Size, By Service,2013–2020 (USD Million)
Table 120 Germany: Oligonucleotide Synthesis Market Size, By Application, 2013–2020 (USD Million)
Table 121 Germany: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 122 Germany: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 123 Germany: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 124 France: Oligonucleotide Synthesis Market Size, By Products & Services, 2013–2020 (USD Million)
Table 125 France: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 126 France: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 127 France: Oligonucleotide Synthesis Market Size, By Application, 2013–2020 (USD Million)
Table 128 France: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 129 France: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 130 France: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 131 U.K.: Oligonucleotide Synthesis Market Size, By Products & Services, 2013–2020 (USD Million)
Table 132 U.K.: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 133 U.K.: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 134 U.K.: Oligonucleotide Synthesis Market Size, By Application, 2013–2020 (USD Million)
Table 135 U.K.: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 136 U.K.: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 137 U.K.: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 138 RoE: Oligonucleotide Synthesis Market Size, By Products & Services, 2013–2020 (USD Million)
Table 139 RoE: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 140 RoE: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 141 RoE: Oligonucleotide Synthesis Market Size, By Application, 2013–2020 (USD Million)
Table 142 RoE: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 143 RoE: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 144 RoE: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 145 Asia-Pacific: Oligonucleotide Synthesis Market Size, By Products & Services, 2013–2020 (USD Million)
Table 146 Asia-Pacific: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 147 Asia-Pacific: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 148 Asia-Pacific: Oligonucleotide Synthesis Market Size, By Application, 2013–2020 (USD Million)
Table 149 Asia-Pacific: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 150 Asia-Pacific: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 151 Asia-Pacific: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 152 Latin America: Oligonucleotide Synthesis Market Size, By Products & Services, 2013–2020 (USD Million)
Table 153 Latin America: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 154 Latin America: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 155 Latin America: Oligonucleotide Synthesis Market Size, By Application, 2013–2020 (USD Million)
Table 156 Asia-Pacific: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 157 Latin America: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 158 Latin America: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 159 Middle East & Africa: Oligonucleotide Synthesis Market, By Products & Services, 2013–2020 (USD Million)
Table 160 Middle East & Africa: Synthesized Oligonucleotides Market Size, By Product, 2013–2020 (USD Million)
Table 161 Middle East & Africa: Synthesized Oligonucleotides Market Size, By Service, 2013–2020 (USD Million)
Table 162 Middle East & Africa: Oligonucleotide Synthesis Market Size, By Application, 2013–2020 (USD Million)
Table 163 Middle East & Africa: Oligonucleotide Synthesis Market Size for Research Applications, By Type, 2013–2020 (USD Million)
Table 164 Middle East & Africa: Oligonucleotide Synthesis Market Size for Therapeutic Applications, By Type, 2013–2020 (USD Million)
Table 165 Middle East & Africa: Oligonucleotide Synthesis Market Size, By End User, 2013–2020 (USD Million)
Table 166 New Product Launches (2012-2015)
Table 167 Partnerships, Agreements, Contracts, and Collaborations (2012-2015)
Table 168 Expansions (2012-2015)
Table 169 Acquisitions (2012-2015)
Table 170 Agilent Technologies, Inc.
Table 171 Bioautomation Corporation
Table 172 Biosearch Technologies
Table 173 Eurofins Genomics
Table 174 Eurogentec S.A.
Table 175 General Electric Company (GE)
Table 176 Gen9, Inc.
Table 177 Gendesign, Inc.
Table 178 Genscript Usa, Inc.
Table 179 Integrated DNA Technologies, Inc. (IDT)
Table 180 Nitto Denko Avecia, Inc. (Avecia)
Table 181 Sigma-Aldrich Corporation
Table 182 Thermo Fisher Scientific, Inc.
Table 183 Trilink Biotechnologies, Inc.


List of Figures (53 Figures)

Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Key Data From Secondary Sources
Figure 7 Key Data From Primary Sources
Figure 8 Synthesized Oligonucleotides Segment to Dominate the Global Oligonucleotide Synthesis Market During the Forecast Period
Figure 9 Intermediate-Scale Synthesis Oligonucleotides Segment to Grow at the Highest Rate (2015-2020)
Figure 10 Custom Oligos Segment to Offer Significant Growth Opportunities
Figure 11 Research Segment to Dominate the Oligonucleotide Synthesis Applications Market (2015)
Figure 12 Diagnostic Laboratories End-User Segment to Grow at the Highest CAGR (2015-2020)
Figure 13 North America Expected to Hold the Largest Share in 2015, Asia-Pacific to Witness Highest Growth (2015-2020)
Figure 14 Synthesized Oligonucleotides Segment to Offer High Growth Opportunities for the Oligonucleotide Synthesis Market
Figure 15 Primers Expected to Be the Major Contributing Segment Between 2015 to 2020
Figure 16 Custom Oligos to Dominate the Synthesized Oligonucleotides Services Segment From 2015 to 2020
Figure 17 PCR to Command the Largest Share of the Research Applications Market in 2015
Figure 18 Rnai Segment Expected to Grow at the Highest CAGR During the Forecast Period
Figure 19 Diagnostic Laboratories Segment to Witness Highest Growth Rate in the Forecast Period
Figure 20 Asia-Pacific to Grow at the Highest Rate During the Forecast Period
Figure 21 Oligonucleotide Synthesis Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 Price Erosion Affecting Industry Growth
Figure 23 Synthesized Oligonucleotides to Grow at the Highest CAGR During the Forecast Period
Figure 24 Asia-Pacific to Grow at the Highest Rate During the Forecast Period
Figure 25 Intermediate Scale Synthesis Segment to Grow at the Highest Rate
Figure 26 Custom Oligonucleotides Dominates the Oligonucleotide Synthesis Market By Services in 2015
Figure 27 North America to Dominate the Reagents Market in 2015
Figure 28 Asia-Pacific to Grow at A Highest CAGR During the Forecast Period
Figure 29 The Diagnostic Applications Segment Offers Lucrative Growth Opportunities for Market Players During the Forecast Period
Figure 30 The PCR Segment to Dominate the Research Applications Market in 2015
Figure 31 Asia-Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 32 The Rnai Segment to Dominate the Therapeutic Applications Market in 2015
Figure 33 Diagnostic Laboratories to Offer Lucrative Growth Opportunities
Figure 34 Asia-Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 35 Asia-Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 36 North America to Dominate the Pharmaceutical and Biotechnology Companies Segment in 2015
Figure 37 North America Oligonucleotide Synthesis Market Snapshot
Figure 38 European Oligonucleotide Synthesis Market Snapshot
Figure 39 Asia Pacific Oligonucleotide Synthesis Market
Figure 40 Latin America Oligonucleotide Synthesis Market Snapshot
Figure 41 Middle East and Africa Oligonucleotide Synthesis Market Snapshot
Figure 42 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2012 and 2015
Figure 43 Market Evolution Framework
Figure 44 Global Oligonucleotide Synthesis Market Share Analysis, By Key Player, 2014
Figure 45 Battle for Market Share: New Product Launches Was the Key Strategy Adopted By Market Players
Figure 46 Oligonucleotide Synthesis Benchmarking for Top 5 Players
Figure 47 Sigma-Aldrich Corporation: Company Snapshot
Figure 48 Eurofins Scientific Group: Company Snapshot
Figure 49 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 50 Agilent Technologies, Inc.: Company Snapshot
Figure 51 Kaneka Corporation: Company Snapshot
Figure 52 General Electric Company (GE): Company Snapshot
Figure 53 Nitto Denko Group: Company Snapshot

Oligonucleotides are single-stranded and short RNA or DNA molecules with applications in research, forensics, and genetic testing. Oligonucleotides are made by chemical synthesis in the laboratory, and are used in therapeutics, cell cultures, library preparations, human identity testing, nucleic acid array-based technology, diagnostics, genetic engineering, next-generation sequencing, synthetic biology, genomics, cloning, and nucleic acid-based detection.

Growth in the market is driven by rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes. The increasing applications of oligonucleotides in nucleic acid array-based technologies, library preparations, next-generation sequencing (NGS), genomics, nucleic acid-base detections, cell cultures, diagnostics, therapeutics, human identity testing, cloning, and genetic engineering and synthetic biology also play a vital role in driving the growth of this market. However, price erosion and lack of regulations for therapeutic oligonucleotides could hinder the growth of this market.

The oligonucleotide synthesis market in this report is segmented on the basis of products and services, applications, end users, and regions. Based on product and services, the market is segmented into synthesized oligonucleotides, reagents, and equipment. The synthesized oligonucleotide segment is further bifurcated on the basis of products and services. On the basis of product, the synthesized oligonucleotide segment is categorized into primers, probes, large-scale synthesis oligos, and intermediate-scale synthesis oligos; whereas, by service, the synthesized oligonucleotide segment is categorized into custom oligos and predesigned oligos. The synthesized oligonucleotides segment is expected to dominate the market by accounting for the largest share in 2015, and it is also expected to experience the highest growth rate during the forecast period. High growth in this segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics. The rising demand for custom oligos also contributes to the growth of the synthesized oligonucleotides market.

On the basis of applications, the oligonucleotide synthesis market is categorized into research, diagnostic, and therapeutic applications. The research applications include PCR, qPCR, sequencing, gene synthesis, and other research applications (nucleic acid-based testing, isothermal nucleic acid technology, binding studies, gel shift assays, and fluorescence in situ hybridization (FISH)). The therapeutic applications segment includes RNAi, DNA/antisense oligos, nucleic acid aptamers, and other therapeutic applications (immunostimulatory agents in immunotherapy applications). The research applications segment is expected to dominate the market; however, the diagnostic applications segment is expected to grow at the highest CAGR during the forecast period. High growth of this segment is attributed to the rapidly growing fields of molecular diagnostics (MDx), emerging technologies such as DNA sequencing and next-generation sequencing (NGS).

The oligonucleotide synthesis market by end user is segmented into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users (private laboratories and hospitals). The diagnostic laboratories segment is expected to grow at the highest CAGR during the forecast period.

Oligonucleotide Synthesis Market

The global oligonucleotide synthesis market is dominated by North America, followed by Europe. The market in Asia is expected to grow at the highest CAGR during the forecast period, owing to factors such as growing availability of synthesized oligos, increase in R&D funding and activities in the APAC region, as well as increasing focus of prominent players on the APAC region.

Key market players include Agilent Technologies, Inc. (U.S.), BioAutomation Corporation (U.S.), BioSearch Technologies (U.S.), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign Inc. (Japan), GE Healthcare (U.K.), Gen9 Inc. (U.S.), GenScript Inc. (U.S.), Integrated DNA Technologies (IDT) (U.S.), Nitto Denko Avecia Inc. (Japan), Thermo Fisher Scientific, Inc. (U.S.), TriLink Biotechnologies (U.S.), and Sigma-Aldrich Corporation (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo